Respiratory medicine · 2026
Association between the PaO2/FiO2-to-PaCO2 ratio and mortality in patients with sepsis: a retrospective study with dual-cohort validation.
СтатьяВалидационное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yuan Sicheng, Dou Li, Tan Yuwei, Wang Jing, Xu Shunjuan, Chen Ruijuan, Guo Tao
Аннотация
BACKGROUND: Sepsis patients face a high mortality risk. Available prognostic biomarkers have certain limitations. This study explored the prognostic utility of the PaO2/FiO2-to-PaCO2 ratio (PFP) in sepsis.
METHODS: This study analyzed MIMIC-IV data on 16,546 patients with sepsis admitted to the ICU and categorized into three groups by PFP values calculated from the first arterial blood gas within 24 h of admission. Associations between PFP and mortality were assessed using Kaplan-Meier, Cox regression, and restricted cubic splines (RCS) analyses, and validated using clinical data from a regional hospital. Machine learning was used to develop predictive models for 28- and 90-day mortality, with and without PFP, to evaluate its predictive strength against existing models.
RESULTS: Mortality rates at 28 and 90 days varied significantly across PFP groups (P < 0.001). Cox regression and Kaplan-Meier analyses showed that lower PFP was associated with higher mortality risk (log-rank P < 0.001), Especially among patients receiving mechanical ventilation, which was confirmed by subgroup and sensitivity analyses.RCS analyses demonstrated a nonlinear association between PFP and mortality (cutoff: 4.85). In external validation, lower PFP was linked to higher mortality risk (cutoff: 4.85; log-rank P < 0.001). Machine learning models for 28- and 90-day mortality identified PFP as a significant predictor. Models including PFP improved integrated discrimination improvement (IDI) compared with baseline models (IDI = 0.6%, P = 0.001; IDI = 0.3%, P = 0.002), indicating improved discrimination.
CONCLUSION: Lower PFP values correlate with higher 28-day and 90-day mortality in septic ICU patients. PFP has modest supplementary prognostic value, mainly in mechanically ventilated patients, not a universal biomarker for all sepsis patients.
METHODS: This study analyzed MIMIC-IV data on 16,546 patients with sepsis admitted to the ICU and categorized into three groups by PFP values calculated from the first arterial blood gas within 24 h of admission. Associations between PFP and mortality were assessed using Kaplan-Meier, Cox regression, and restricted cubic splines (RCS) analyses, and validated using clinical data from a regional hospital. Machine learning was used to develop predictive models for 28- and 90-day mortality, with and without PFP, to evaluate its predictive strength against existing models.
RESULTS: Mortality rates at 28 and 90 days varied significantly across PFP groups (P < 0.001). Cox regression and Kaplan-Meier analyses showed that lower PFP was associated with higher mortality risk (log-rank P < 0.001), Especially among patients receiving mechanical ventilation, which was confirmed by subgroup and sensitivity analyses.RCS analyses demonstrated a nonlinear association between PFP and mortality (cutoff: 4.85). In external validation, lower PFP was linked to higher mortality risk (cutoff: 4.85; log-rank P < 0.001). Machine learning models for 28- and 90-day mortality identified PFP as a significant predictor. Models including PFP improved integrated discrimination improvement (IDI) compared with baseline models (IDI = 0.6%, P = 0.001; IDI = 0.3%, P = 0.002), indicating improved discrimination.
CONCLUSION: Lower PFP values correlate with higher 28-day and 90-day mortality in septic ICU patients. PFP has modest supplementary prognostic value, mainly in mechanically ventilated patients, not a universal biomarker for all sepsis patients.